共 65 条
[1]
Saha SK(2016)Forty-year trends in cholangiocarcinoma incidence in the U.S.: intrahepatic disease on the rise Oncologist 21 594-599
[2]
Zhu AX(2011)Chemotherapy outcomes for the treatment of unresectable intrahepatic and hilar cholangiocarcinoma: a retrospective analysis Gastrointest Cancer Res 4 155-160
[3]
Fuchs CS(2013)Chemotherapy for cholangiocarcinoma: an update World J Gastrointest Oncol 5 171-176
[4]
Brooks GA(2000)Surgery for hilar cholangiocarcinoma: French experience in a collective survey of 552 extrahepatic bile duct cancers J Hepato-biliary-pancreatic Surg 7 128-134
[5]
Eckmann KR(2007)Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution Ann Surg 245 755-762
[6]
Patel DK(2015)Perioperative management of hilar cholangiocarcinoma J Gastrointest Surg 19 1889-1899
[7]
Landgraf A(2015)Percutaneous preoperative biliary drainage for resectable perihilar cholangiocarcinoma: no association with survival and no increase in seeding metastases Ann Surg Oncol 22 1156-1163
[8]
Ramirez-Merino N(2014)Oncological benefit of preoperative endoscopic biliary drainage in patients with hilar cholangiocarcinoma J Hepato-biliary-pancreatic Sci 21 533-540
[9]
Aix SP(2005)Surgery for hilar cholangiocarcinoma; a 10 year experience of a tertiary referral centre in the UK Eur J Surg Oncol 31 533-539
[10]
Cortes-Funes H(2017)Oncologic effects of preoperative biliary drainage in resectable hilar cholangiocarcinoma: Percutaneous biliary drainage has no adverse effects on survival J Surg Oncol 117 1267-1277